The new study, presented this month at the European Congress on Obesity in Venice, Italy, focused solely on Wegovy, an ...
The study found that the majority of people on Wegovy lost weight, on average 10% of their body weight, in the first 15 ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
A new poll found that one in eight American adults had used a GLP-1 drug, with half of those people still taking the ...
Even as GLP-1 medicines may increase fertility, little is known about their safety during pregnancy. The drugs’ makers, Novo ...
Among the most prevalent sleep disorders are obstructive sleep apnea (OSA) and insomnia—which often occur together. As the authors of the present study note, an estimated 30% to 40% of those ...
Weight-loss drugs called GLP-1 agonists help users shed fat, and with it the negative health effects of obesity. This can ...
Research has shown that even a moderate amount of excess weight can increase the risk of sleep apnea significantly. A study published in the American Journal of Epidemiology found that obese ...